EWTX
Edgewise Therapeutics Inc
39.60$
-1.1%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | +19.0% | -1.5% | +1.7% | +328.8% | -53.8% | -47.7% | +2.3% | – | – | – | – | – | |
| – | – | -130.5% | – | – | – | -152.3% | – | – | – | – | – | – | |
| – | +16.4% | +0.0% | +10.8% | +5.0% | +12.9% | +1.1% | -8.7% | +11.7% | +16.3% | -2.2% | +11.5% | – | |
| – | +9.0% | +14.3% | +5.2% | +10.5% | +11.7% | +0.3% | -1.6% | +3.6% | +32.1% | -7.4% | +25.6% | – | |
| – | +15.0% | +2.6% | +9.7% | +6.1% | +12.6% | +0.9% | -7.3% | +10.0% | +19.5% | -4.4% | +15.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -86.6% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.